Rabacfosadine
Rabacfosadine (GS-9219) is a novel prodrug designed to selectively deliver the cytotoxic nucleotide analog PMEG into tumor lymphocytes. It has been investigated in preclinical in vivo models for the treatment of B-cell lymphomas and leukemias, demonstrating targeted anti-tumor activity.
Product Specifications
CAS Number
859209-74-8
Product Name Alternative
VDC 1101, VDC1101, VDC-1101, Rabacfosadine, GS9219, GS-9219, GS 9219, Nucleoside Antimetabolite/Analog, NucleosideAntimetabolite, Nucleoside Antimetabolite, Analog
Field of Research
Cell Biology, Molecular Biology
Purity
99.06% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.27 mM) ; DMSO:80 mg/mL (151.94 mM)
Smiles
C (COCP (N[C@H] (C (OCC) =O) C) (N[C@H] (C (OCC) =O) C) =O) N1C=2C (=C (NC3CC3) N=C (N) N2) N=C1
Molecular Formula
C21H35N8O6P
Molecular Weight
526.53
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RDA06096-01 100 mg
(2-Methyl-2,3-dihydro-1-benzofuran-5-yl) methanol
Sign In for Pricing
View Details 
